Sharon R. Flanagan

SHARON FLANAGAN is a member of the firm’s Management Committee and Executive Committee and has over 25 years of experience representing companies in a broad range of merger and acquisition transactions, securities offerings and corporate governance matters, with a particular focus on the life sciences/healthcare and technology industries. Sharon also serves as the San Francisco office managing partner, and is a leader of the firm’s Global Life Sciences practice. She was named to the Daily Journal’s 2021 “Top 100 Lawyers in California” list. She has been named an LMG Life Sciences “Life Sciences Star” in the Mergers & Acquisitions category (2018–2024). She was also selected by The Recorder as one of “10 Power Players” in California as lawyers who stand out as “trailblazers, mentors and advocates for women in tech.”

Sharon also advises a number of public companies on corporate governance, disclosure and other SEC compliance matters, as well as proxy advisory firm matters, stockholder proposals and corporate governance best practices.

Consistently recognized for her work on a number of significant transactions, Sharon was recognized by Chambers USA for Corporate/M&A (California: San Francisco, Silicon Valley, 2020–2025), Capital Markets: Debt & Equity: Western United States (Nationwide, 2019–2025), and Capital Markets: Debt & Equity (California, 2013–2025). She has also been recognized in the 2011 through 2022 editions of The Best Lawyers in America in the area of Corporate Law, as well as M&A Law and Corporate Compliance Law. In 2012, Sharon was named The Best Lawyers’ 2013 San Francisco Corporate Law “Lawyer of the Year.” She was also recommended in Healthcare: Life Sciences, Capital Markets and M&A in the 2013–2017 editions of Legal 500 U.S. In 2011, The American Lawyer named Sharon as one of “45 Under 45” – “the best of the best among young women lawyers in the Am Law 200.” She was named to the Daily Journal’s list of the “Top 25 Women Corporate and Transactional Lawyers” in California.

Notable transactions include representing the following:

• Roche (ROG.S) in its purchase of Poseida Therapeutics (NSDQ: PSTX), a specialist in CART-T immune cell therapies for $1.5 billion in cash and contingent value rights
• Roche in its acquisition of Carmot Therapeutics Inc., a clinical-stage GLP-1 company, for an upfront payment of $2.7 billion and additional milestone payments of up to $400 million
• Genentech, Inc.  in its sale of a biologics manufacturing facility to contract drug manufacturer, Lonza for $1.2 billion in cash
• ServiceTitan, Inc. a leading software provider for the trades,  in its acquisition of Schedule Engine, a leading provider of online booking for home and commercial services
• ServiceTitan, Inc. in its acquisition of FieldRoutes, a cloud-based and mobile SaaS provider in the pest control and lawn care industry
• Flex Ltd., an American multinational manufacturing company domiciled in Singapore, and its Fremont, California-based solar technology subsidiary, Nextracker Inc. (Nasdaq: NXT), in its $662.5 million combined primary (synthetic secondary) and secondary underwritten public offering of its Class A common stock by Nextracker and certain selling stockholders; its upsized $734.2 million initial public offering; and the spinoff of its remaining interests in Nextracker Inc. to Flex shareholders on a pro rata basis
• ContextLogic (NASDAQ: LOGC), an eCommerce company that operates the Wish platform, in its sale of substantially all its assets sale to Singapore-based, Qoo10 to for $173 million
• Flex Ltd. in its sale of $500 million of convertible preferred equity in Nextracker to TPG Rise Climate.
• DaVita, Inc. in the formation of Mozarc Medical, its joint venture with Medtronic, a kidney care-focused medical device company focused on developing broad suite of novel kidney care products and solutions
• Roche in its acquisition of diagnostics company, GenMark (NSDQ:GNMK) for $1.8 billion in cash
• ServiceTitan, Inc. in its acquisition of Aspire Software, a landscaping business management software provider 
• Roche in its acquisition of Ignyta, Inc. (NASDAQ: RXDX), a cancer therapy company for $1.7 billion in cash, which LMG Life Sciences named as one of its “Deals of the Year” 
• Palo Alto Networks, Inc. in its acquisition of cloud-delivered SD-WAN provider, CloudGenix Inc., for $420 million
• Palo Alto Networks, Inc. in its acquisition of cloud native security platform, Twistlock, for $410 million in cash
• Fortive Corporation in its acquisition of the Advanced Sterilization Products business from J&J for $2.8 billion in cash in a binding offer structured transaction
• DSC Logistics in the sale of a majority interest to South Korean logistics company, CJ Logistics
• Palo Alto Networks, Inc. in its acquisition of cybersecurity company, Demisto, for $560 million in cash and stock
• Palo Alto Networks, Inc. in its acquisition of serverless security company, PureSec
• Splunk Inc., a leading security company, in its acquisition of cloud monitoring leader SignalFX for $1.05 billion in cash and stock
• PayPal Inc. in its acquisition of Xoom Corporation (NASDAQ: XOOM), a leading international digital money transfer provider, for $890 million in cash
• Roche in its acquisition of ForeSight VISION4, a biotechnology company focused on drug delivery for treatment of retinal diseases
• Genentech, Inc. in its acquisition of Seragon Pharmaceuticals, Inc., a biotechnology company focused on the treatment of breast cancer, for up to $1.725 billion in cash
• eBay Inc. in the sale of Skype Technologies to Silver Lake Partners for $2 billion
• PayPal Inc. in its acquisition of Braintree, operator of the Braintree and Venmo payments platforms for $800 million 
• HP Inc. in its sale of certain software assets to OpenText
• Intuit Inc. in its acquisition of Exactor, a leading cloud-based SaaS technology provider
• Roche Molecular Systems in its acquisition of Genia Technologies, a DNA sequencing company, for $125 million in cash and up to $225 million in milestones
• PayPal Inc. in its acquisition of Zong SA, a Swiss mobile payments company
• PayPal Inc. in its acquisition of Swift Financial, a leading provider of working capital solutions to small businesses
• Medivation in its acquisition of a Phase III PARP inhibitor program from BioMarin for $570 million
• Hansen Medical (NASDAQ: HNSN) in its sale to Auris Surgical Robotics
• Roche in its acquisition of genomics software company, BINA Technologies Inc.
• Genentech, Inc. in its acquisition of NLRP3 inhibitor development-stage company, Jecure Therapeutics
• Roche in multiple options to acquire companies, including its collaboration and option to acquire Versant incubator, Inception 3, an early stage hearing loss development program and Inception 5, an early stage multiple sclerosis development program; its collaboration and option to acquire epigenetic company, Constellation Pharmaceuticals; and its collaboration and option to acquire Forma Therapeutics, a development-stage oncology company
• Genentech, Inc. in its purchase from Lonza of a biologic manufacturing facility in Singapore and sale of a biologic manufacturing facility to Lonza in Spain
• Splunk Inc. in its acquisition of Phantom Cyber, a cybersecurity company, for $350 million
• PayPal Inc. in numerous acquisitions, including, the acquisition of Modest, a mobile commerce platform; Israeli cybersecurity company CyActive; and mobile payments company, Card.io 
• eBay Inc. in numerous acquisitions, including the acquisition of eCommerce company, Milo; customer acquisition company, Iron Pearl; and Israeli-based analytics company, SalesPredict
• Baxter International Inc. in the formation and spinoff of its worldwide cardiovascular business to Edwards Lifesciences
• GE Medical Systems in the sale of its global radiotherapy service business to Varian Medical Systems
• Aon Corporation in its sale of its auto insurance business AIS to Mercury Insurance
• URS Corporation in its acquisition of defense contractor, EG&G Technical Services and Lear Siegler Services from The Carlyle Group
• KKR Financial Holdings in its conversion from a REIT into a master LLC structure
• DaVita Inc., a Fortune 500 healthcare company, in multiple high-yield notes offerings, including its acquisition financing for HealthCare Partners
• The underwriters for multiple equity and debt offerings by healthcare REIT, Healthpeak.
• Merrill Lynch, Pierce, Fenner & Smith Incorporated and Goldman, Sachs & Co. in the initial public offering and multiple common stock and convertible notes offerings for retailer, Restoration Hardware
• Internet Corporation for Assigned Names and Numbers (ICANN), a cross-community international working group in the historic and closely followed transition of the oversight of ICANN and the internet domain name system from the U.S. government to a multistakeholder community

• American Bar Association
• California Bar Association; former Vice-Chair of the Corporations Committee of the State Bar of California
• Board of Trustees and Member of the Executive Committee of the Exploratorium